Patents Assigned to Navitor Pharmaceuticals, Inc.
  • Methods of treatment using an mTORC1 modulator
    Patent number: 11723890
    Abstract: The present invention relates to methods, compositions, and unit dosage forms useful for selectively modulating mTORC1 activity.
    Type: Grant
    Filed: November 2, 2020
    Date of Patent: August 15, 2023
    Assignee: Navitor Pharmaceuticals, Inc.
    Inventors: Steven Leventer, Steven D. Targum
  • Polymorphic compounds and uses thereof
    Patent number: 11697633
    Abstract: The present invention relates to compounds and methods useful for selectively modulating mTORC1 activity.
    Type: Grant
    Filed: May 5, 2022
    Date of Patent: July 11, 2023
    Assignee: Navitor Pharmaceuticals, Inc.
    Inventor: Silvia Lenzini
  • Modulators of Sestrin-GATOR2 interaction and uses thereof
    Patent number: 11679090
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Grant
    Filed: November 30, 2020
    Date of Patent: June 20, 2023
    Assignee: Navitor Pharmaceuticals, Inc.
    Inventors: Eddine Saiah, George Vlasuk
  • Polymorphic compounds and uses thereof
    Patent number: 11345654
    Abstract: The present invention relates to compounds and methods useful for selectively modulating mTORC1 activity.
    Type: Grant
    Filed: October 24, 2019
    Date of Patent: May 31, 2022
    Assignee: NAVITOR PHARMACEUTICALS, INC.
    Inventor: Silvia Lenzini
  • Heteroaryl Rheb inhibitors and uses thereof
    Patent number: 11339144
    Abstract: The present invention provides compounds of general Formula I and I?: compositions thereof, and methods of using same to treat Rheb-mediated disorders.
    Type: Grant
    Filed: April 9, 2018
    Date of Patent: May 24, 2022
    Assignee: NAVITOR PHARMACEUTICALS, INC.
    Inventors: Sarah Mahoney, Lisa Molz, Sridhar Narayan, Eddine Saiah
  • Modulators of Sestrin-GATOR2 interaction and uses thereof
    Patent number: 11325924
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Grant
    Filed: July 29, 2020
    Date of Patent: May 10, 2022
    Assignee: NAVITOR PHARMACEUTICALS, INC.
    Inventors: Kristina Michelle Fetalvero, Sridhar Narayan, David John O'Neill, Eddine Saiah, Shomit Sengupta
  • Rapamycin analogs and uses thereof
    Patent number: 10980784
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Grant
    Filed: June 17, 2019
    Date of Patent: April 20, 2021
    Assignee: NAVITOR PHARMACEUTICALS, INC.
    Inventors: Eddine Saiah, David John O'Neill, Seong Woo Anthony Kang
  • Modulators of Sestrin-GATOR2 interaction and uses thereof
    Patent number: 10912750
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Grant
    Filed: April 25, 2018
    Date of Patent: February 9, 2021
    Assignee: NAVITOR PHARMACEUTICALS, INC.
    Inventors: Eddine Saiah, George Vlasuk
  • Phenyl amino piperidine mTORC inhibitors and uses thereof
    Patent number: 10844013
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Grant
    Filed: August 7, 2019
    Date of Patent: November 24, 2020
    Assignee: NAVITOR PHARMACEUTICALS, INC.
    Inventors: David John O'Neill, Eddine Saiah, Seong Woo Anthony Kang, Andrew Brearley, Jonathan Bentley
  • Modulators of Sestrin-GATOR2 interaction and uses thereof
    Patent number: 10752644
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Grant
    Filed: July 18, 2019
    Date of Patent: August 25, 2020
    Assignee: NAVITOR PHARMACEUTICALS, INC.
    Inventors: Kristina Michelle Fetalvero, Sridhar Narayan, David John O'Neill, Eddine Saiah, Shomit Sengupta
  • Rapamycin analogs and uses thereof
    Patent number: 10683308
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Grant
    Filed: September 9, 2016
    Date of Patent: June 16, 2020
    Assignee: Navitor Pharmaceuticals, Inc.
    Inventors: Eddine Saiah, David John O'Neill
  • PYRROLE mTORC INHIBITORS AND USES THEREOF
    Publication number: 20190389843
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Application
    Filed: November 8, 2017
    Publication date: December 26, 2019
    Applicant: Navitor Pharmaceuticals, Inc.
    Inventors: David John O'Neill, Eddine Saiah, Seong Woo Anthony Kang, Andrew Brearley, Jonathan Bentley
  • Phenyl amino piperidine mTORC inhibitors and uses thereof
    Patent number: 10414727
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Grant
    Filed: November 8, 2017
    Date of Patent: September 17, 2019
    Assignee: Navitor Pharmaceuticals, Inc.
    Inventors: David John O'Neill, Eddine Saiah, Seong Woo Anthony Kang, Andrew Brearley, Jonathan Bentley
  • Modulators of sestrin-GATOR2 interaction and uses thereof
    Patent number: 10414782
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Grant
    Filed: May 9, 2018
    Date of Patent: September 17, 2019
    Assignee: Navitor Pharmaceuticals, Inc.
    Inventors: Kristina Michelle Fetalvero, Sridhar Narayan, David John O'Neill, Eddine Saiah, Shomit Sengupta
  • Modulators of sestrin-GATOR2 interaction and uses thereof
    Patent number: 10100066
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Grant
    Filed: October 21, 2016
    Date of Patent: October 16, 2018
    Assignee: Navitor Pharmaceuticals, Inc.
    Inventors: Kristina Michelle Fetalvero, Sridhar Narayan, David John O'Neill, Eddine Saiah, Shomit Sengupta